PHOENIX, July 19, 2016 /PRNewswire/ -- Lotus Bio-Technology Development Corp. (OTC: LBTD), (the "Company") is pleased to announce upon evaluation, that its latest market research indicates a strong continuing upsurge in China's organic consumables industry.
Growing rapidly from what is currently just a fractional segment of China's food industry, the Natural and organic products sector is rising consistently. According to Biofach China, China is the second largest consumer market in the world, where the growth of consumption of Chinese organic products is expected to exceed the average rate, globally.
In 2008, the total value of organic production reached a height in the range of 16 billion RMB ($ 2.4 billion US), with exported organic products exceeding $500 million US dollars, along with the domestic organic market reaching $1.1 billion US dollars. According to Biofach, the world's largest organic trade fair, the consumption of organic food literally tripled between 2007 and 2012.
As recent food safety issues have gained exposure, the organic product industry has correspondingly experience data transference in consumer buying habits in recent years. Particularly, consumers in the white collared demographic, as well as foreigners settling in the region, have become increasingly motivated to invest more in better quality food. Accordingly, research from Mintel on consumer lifestyles in China reveals that 80% of urban Chinese consumers claim that organic food and drink products are worth paying more for.
"We are very pleased to be stepping into this advantageous segment of the industry. The opportunities opening before us are a significant indicator of how robust the growth potential is in this sector," stated said Michael Palethorpe, President of Lotus. He concluded: "We firmly believe that the greatest potential for a high level of success is when timing and opportunity meet. At this stage in the game in the organic food market in China, it's evident that the growth and revenue potential here can be exponential."
Lotus Bio-Technology has diligently established long-term relationships and strategic partnership with various biological companies and medical distribution companies in China, including Hunan Cangshi, a successful proprietor, developer and producer of consumer related organic products, Phyto Nutraceutical Inc., which is developer, manufacturer, exporter and primary supplier of plant extracts and Changsha Huakang Biotechnology Development Co., Ltd, a company which specializes in extracting active ingredient from natural herbs and plants. Lotus also collaborates closely with Shanghai Ninth People's Hospital and Shanghai Putuo People's Hospital and as their direct supplier, the Company provides patients with premium quality of organic consumer products.
About Lotus Bio-Technology Development Corp. Lotus Bio-Technology is an Arizona based bio-technology development company that specializes in the refining of organic materials and the production of natural consumer related products. The Company has the rights to farmland in China of 1,000 hectares which is approximately 100 football fields combined. Our mandate is to grow various plants under strict organic standards and produce organic based consumer related products which completely natural. The products will strike a balance between affordability and produced from an environmentally responsible way and not be grown with pesticides, synthetic fertilizers, antibiotics, growth hormones or other dangerous chemicals while ensuring a solid financial return for our shareholders. The Company is a publicly traded company having its common shares quoted on the OTC Markets under the symbol LBTD.
Cautionary Note Regarding Forward-Looking Statements: This news release contains forward-looking statements about our business or financial condition and prospects that reflect our assumptions and beliefs based on information currently available. We can give no assurance that the expectations indicated by such forward-looking statements will be realized. There may be other risks and circumstances that we are unable to predict. When used in this news release, words such as "believes," "expects," "intends," "plans," "anticipates," "estimates" and similar expressions are intended to identify forward-looking statements, although there may be certain forward-looking statements not accompanied by such expressions. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including risks discussed in the company's periodic reports that are filed with the Securities and Exchange Commission and available on its website (www.sec.gov). All forward-looking statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by these factors other than as required under the securities laws. The Company does not assume a duty to update these forward-looking statements.
SOURCE Lotus Bio-Technology Development Corp.